NHI-2
SIGMA/SML1463 - ≥98% (HPLC)
Synonym: 1-
CAS Number: 1269802-97-2
Empirical Formula (Hill Notation): C17H12F3NO3
Molecular Weight: 335.28
Linear Formula: C17H12F3NO3
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C17H12F3NO3/c1-24-16(2 |
| InChI key | YPPFWRWCZNXINO-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | ON(C(C(OC)=O)=C1)C2=C1C(C |
| solubility | DMSO: 20 mg/mL, clear |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | NHI-2 is an inihbitor of Lactate dehydrogenase-A (LDH-A, LDHA), a key enzyme necessary to sustain glycolysis, the major pathway used by many cancer cells for cell growth and proliferation (the Warburg effect). NHI-2 has anti-glycolytic activity against a variety of cancer cells. NHI-2 inhibited cell growth of pancreatic cancer LPC006 and PANC-1 cells and enhanced the antiproliferative effects of Gemcitabine and caused apoptosis in colon cancer HCT116 cells. |
| Biochem/physiol Actions: | NHI-2 is an inihbitor of Lactate dehydrogenase-A (LDH-A, LDHA). |
| Biochem/physiol Actions: | NHI-2 possesses highr cell permeability. |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

